Category: National

New Delhi [India], January 6: On January 5 and 6, 2026, the IndiaAI Mission, the Ministry of Electronics and Information Technology, the Government of Assam and IIT Guwahati held a two-day Human Capital Working Group meeting. On paper, it appeared as yet another policy consultation. At ground level, it was a fresh start.

It did not involve selling AI as a silver bullet. It was about asking embarrassing questions. Who benefits from AI? Who gets displaced? Who gets left behind when there is not enough speed, and who gets trampled when there are no guardrails?

The discussions will directly contribute to the India AI Impact Summit 2026, which will take place in New Delhi. That fact alone signals seriousness. Human capital is no longer a periphery. It is the spine.

Guwahati as the Policy Testbed

There is symbolism in Assam hosting this meeting. India’s AI policy has been metro-heavy. New Delhi drafts. Bengaluru builds—Hyderabad scales. Holding national AI human capital talks in Guwahati turns that equation on its head.

Prof. Devendra Jalihal, Director of IIT Guwahati, set the pace. He positioned the institute not just as a technology hub, but as a gathering ground where policy, academia, industry and students intersect. Student involvement was not cosmetic. It reflected a generation that understands AI will shape their jobs whether policymakers like it or not.

It was also here that regional perspectives entered national policy thinking. Northeast India is not an AI appendix. It is an inclusion-and-adoption test case.

Human Capital and Lifelong Learning: The Big Pivot

If there was one phrase repeated across sessions, it was this: skilling is not enough.

Prof. T. G. Sitharam, Chair of the Human Capital Working Group, was direct. Piecemeal skilling programmes will not survive the AI economy. India needs lifelong learning ecosystems that value flexibility, judgment and human-centred capabilities alongside technical skills.

Translation: teaching Python once and calling it future-ready is a bad joke.

The focus shifted from automation to augmentation. AI should expand human capability, not replace it. This is not only a philosophical shift, but an economic one. Given India’s workforce scale, mass displacement is not hypothetical. It is a political and social reality.

This concern was reinforced by Shri K. S. Gopinath Narayan, Principal Secretary (IT), Government of Assam, who cautioned that unchecked automation could widen inequalities across regions and sectors. His emphasis on micro-skilling, continuous learning and AI literacy framed these not as elite skills, but as public capabilities.

India AI, the Global South and the Sovereignty Question

Ms Shikha Dahiya, Joint Director, IndiaAI, explained why the India AI Impact Summit 2026 matters beyond India. It is not just about domestic readiness, but about shaping a Global South narrative on AI.

IndiaAI’s work on compute capacity, indigenous datasets and homegrown models was positioned as foundational to human capital development. Without sovereign AI infrastructure, human capital strategies risk collapsing into dependency.

This matters because AI power is already concentrated globally. Shri Syedain Abbasi, Special Chief Secretary, Government of Assam, did not soften his words. AI today is not merely a tool, but an autonomous agent. That changes the risk profile entirely.

He also voiced what many policy rooms avoid acknowledging. India’s traditional IT and outsourcing employment model is vulnerable. If AI capability remains concentrated among a few global players, job erosion will not be gradual. It will be abrupt.

The response, as discussed, lies in indigenous computing, public–private collaboration and differentiated skilling pathways across education levels.

Human Capital and Gender Inclusion in the AI Workforce

One of the most grounded discussions focused on gender-responsive strategies for the AI transition. This was not a checkbox session.

Panellists highlighted risks already visible on the ground—automation of entry-level roles with high female participation. Wage gaps widened by unequal access to AI skills—bias embedded in data and algorithms.

The message was consistent. Inclusion cannot be retrofitted. It must be built into AI systems, skilling programmes and adoption strategies from the start.

Moderated by Ms. Arpitha Desai of The Asia Group, the panel brought together voices from government, industry and academia. The focus was on explainable AI, adoption-led reskilling and ecosystem-driven policy interventions. Not slogans. Systems.

Reinventing Education for the Cognitive Age

Perhaps the most consequential session centred on education reform. The term “cognitive age” was used deliberately.

The panel on redefining education examined how AI is reshaping learning objectives, pedagogy and assessment. Rote memorisation was declared obsolete. Process-oriented and cognitive learning took centre stage.

Used well, AI can personalise learning and reduce administrative burdens on teachers. Used poorly, it can reduce education to scaled content consumption.

Panellists stressed the need for human-centric, community-tested AI tools and closer alignment between education systems and fast-evolving industry requirements. Adaptability, critical thinking, collaboration and lifelong learning emerged as non-negotiables.

This is where India’s demographic advantage will either compound or collapse.

Human Capital Implications for the India AI Impact Summit 2026

The Guwahati meeting is not an end in itself. It is a funnel.

Its outcomes will be consolidated into recommendations that inform national policy decisions and global-level discussions at the India AI Impact Summit 2026. That summit will culminate in leaders’ plenaries and working group outcomes in New Delhi.

The throughline is unmistakable. India is positioning human capital not as collateral damage of AI, but as its primary beneficiary.

This aligns squarely with the vision of Viksit Bharat 2047. Growth without dignity is not development. AI without inclusion is not progress.

India AI Impact Summit 2026
India AI Impact Summit 2026 – official summit portal

Official IndiaAI Mission 
Ministry of Electronics & Information Technology – IndiaAI Mission official page

PNN News

New Delhi [India], January 6: For decades, power distribution was the weakest link in India’s energy chain. Now, after years of bruising reforms, the numbers are finally blinking green.

Power distribution sits where ambition meets reality. You can build solar parks, commission wind farms, and talk up electric mobility all day. But if distribution utilities bleed cash and leak power, the system collapses quietly. That has been India’s recurring problem.

High Aggregate Technical and Commercial losses. Chronic debt. Endless bailouts. And a reputation for being reform-proof.

Something has shifted.

The India power distribution sector turnaround is no longer a policy slide or a hopeful projection. FY 2024–25 numbers show measurable change. Not cosmetic. Structural.

Why the Distribution Sector Matters More Than Ever

India’s clean energy target of 500 GW of non-fossil capacity isn’t just about generation. It depends on whether distribution utilities can absorb variable renewables, manage decentralised grids, and support electric mobility without blowing financial fuses.

DISCOMs are the gatekeepers. If they’re weak, renewable integration stalls. If they’re broke, grid upgrades don’t happen. If they’re opaque, investors stay cautious.

That’s why the government’s reform strategy has focused relentlessly on distribution. Not glamorous. Not headline-friendly. But unavoidable.

The results are now visible.

FY 2024–25: Numbers That Actually Matter

Let’s start with efficiency. Aggregate Technical and Commercial losses have dropped from 22.62 percent in FY14 to 16.16 percent in FY25. That’s not a rounding error. That’s years of metering, feeder separation, billing discipline, and less tolerance for leakage.

Then comes the money gap that haunted DISCOMs for years. The Average Cost of Supply minus Average Revenue Realised gap has narrowed sharply.

From ₹0.78 per unit in FY14 to just ₹0.11 per unit in FY25. Translation: utilities are finally recovering what it costs to supply power.

And then the headline moment. For the first time ever, India’s power distribution utilities posted a positive Profit After Tax. ₹858 crore in FY25. Compare that to a loss of ₹67,962 crore in FY14. That swing didn’t happen by accident.

Payment discipline has also tightened. Outstanding dues to generating companies collapsed by 96 percent. From ₹1.39 lakh crore in 2022 to ₹5,747 crore by December 2025. Payment cycles shortened from 176 days in FY21 to 120 days in FY25. Not perfect, but moving in the right direction.

Perhaps the most telling signal is this. Accumulated losses declined year-on-year for the first time. From ₹6.92 lakh crore in FY24 to ₹6.39 lakh crore in FY25. That’s a psychological break from the past.

What Changed Under the Hood

This turnaround didn’t come from one scheme or one announcement. It came from layering reforms until escape routes closed.

Late Payment Surcharge Rules forced utilities to respect contracts. Miss payments, pay penalties. Simple. Effective.

Tariff rationalisation rules pushed states to stop pretending electricity is free. Costs had to be recognised. Subsidies had to be accounted for transparently.

Financial discipline was reinforced by linking borrowing permissions to reform performance. Want more fiscal headroom? Fix your DISCOM first.

Operationally, smart metering and infrastructure upgrades under the Revamped Distribution Sector Scheme began plugging leakages at the consumer end. Not dramatic. Just relentless.

Union Power Minister Manohar Lal has repeatedly hammered the same point. A future-ready power sector needs financially strong distribution utilities. Affordable power doesn’t mean bankrupt utilities. It means efficient ones.

The Legacy Burden Still Looms Large

Now, let’s not get carried away.

Despite progress, distribution utilities still carry ₹6.39 lakh crore in accumulated losses and ₹7.18 lakh crore in debt as of FY25. Nearly 80 percent of this burden sits with a handful of states. Tamil Nadu. Rajasthan. Maharashtra. Andhra Pradesh. Uttar Pradesh. Telangana. Madhya Pradesh. Karnataka.

These aren’t small players. They shape national outcomes.

The India power distribution sector turnaround will stall if these structural pockets aren’t addressed. Political reluctance to raise tariffs. Delayed subsidy payments. Operational inefficiencies. They still exist.

Reforms have arrested the fall. Sustaining the climb is the real test.

Why This Matters for Viksit Bharat 2047

The government has framed distribution reform as a pillar of Viksit Bharat 2047. That’s not rhetoric. It’s arithmetic.

A green, digital energy future needs utilities that can invest. In smart grids. In storage integration. In EV charging infrastructure. None of that happens if balance sheets are broken.

The Electricity Distribution (Accounts and Additional Disclosure) Rules, 2025 aim to standardise accounting and expose financial reality. Transparency is uncomfortable. But it’s necessary.

Additional prudential norms now tie access to finance with performance benchmarks. No more blank cheques.

Amendments to electricity rules enforce timely cost adjustments and realistic tariffs. Politics aside, electricity has to be paid for.

Together, these measures are reshaping incentives. Slowly. Sometimes painfully. But clearly.

The Quiet Confidence Behind the Numbers

What’s striking is the tone shift. Earlier, every improvement came with caveats and disclaimers. Now, officials talk about sustaining gains, not rescuing failures.

That’s a subtle but important change.

The distribution sector isn’t fixed. But it’s no longer in free fall. And that alone changes investor confidence, renewable integration timelines, and state-level accountability.

For India’s energy transition, this is foundational work. Unsexy. Uncelebrated. But decisive.

Read More

Kolkata (West Bengal) [India], January 5: Santoor Ashram, a cultural NGO dedicated to empowering financially underprivileged student artists and founded by Santoor Maestro Pt. Tarun Bhattacharya, successfully hosted Aikyam – Series 2 at Uttam Mancha, Kolkata, on the 2nd and 3rd of January 2026. This two-day festival of classical music and performing arts was organised in partnership with Jagriti Dham, resulting in a meaningful collaboration that honoured India’s deep artistic heritage while providing a vital platform for the development of young, emerging talent.

True to its meaning—unity—Aikyam brought together legendary maestros and accomplished performers on a single platform. Designed as a harmonious blend of experience and aspiration, the programme allowed established icons to share the stage with budding artists, inspiring both audiences and performers.

The two-day cultural showcase received an overwhelming response, with a packed auditorium and enthusiastic participation from music and art enthusiasts across Kolkata. Jagriti Dham, widely regarded as the best old age home in Kolkata and a premier senior living community, actively participated in and supported the initiative, contributing to an inclusive and emotionally enriching cultural experience.

One of the major highlights of Aikyam – Series 2 was the recognition and felicitation of artists who demonstrated remarkable promise across various music and dance forms. In a heartfelt gesture, these talented performers were felicitated by Jagriti Dham, reinforcing the organisation’s commitment to social responsibility, cultural preservation, and encouragement of artistic talent.

Ravindra Chamaria, Chairman and Managing Director of Infinity Group and Founding Trustee of Jagriti Dham, remarked, “Aikyam – Series 2 beautifully showcases how art can nurture harmony and growth. Jagriti Dham is proud to support Santoor Ashram in empowering young artists and celebrating creativity rooted in our cultural values.”

Another deeply moving moment of the programme was the felicitation and honouring of Dr. Malaya Gangopadhyay, the senior-most resident member of Jagriti Dham, by Padma Bhushan awardee Pt. Vishwa Mohan Bhatt, the globally renowned musician who invented and popularised the Mohan Veena. This gesture symbolised respect for wisdom, age, and lifelong contribution, leaving a strong emotional impact on the audience.

Adding a special musical milestone to the event, Pt. Tarun Bhattacharya unveiled and presented a Signature Tune exclusively composed for Jagriti Dham. The soulful composition reflected the values of serenity, dignity, spirituality, and cultural richness that the esteemed senior living community represents, and received warm appreciation from the audience.

Beyond the stage performances, the festival fostered meaningful intergenerational connections, bringing together senior residents, young performers, and maestros to share stories, blessings, and words of encouragement.

Aikyam – Series 2 showcased a distinguished line-up of maestros and performers spanning classical vocal, instrumental, and dance disciplines, creating a deeply immersive cultural experience over two evenings. Every performance was thoughtfully curated to reflect a seamless balance between tradition and contemporary expression.

Speaking about the initiative, Pt. Tarun Bhattacharya said, “Aikyam is not merely a concert series; it is a movement that unites generations, backgrounds, and artistic expressions. With Jagriti Dham’s support, we created a platform where young, underprivileged artists could perform alongside legends and feel truly recognised and valued.”

The collaboration marked a proud and meaningful milestone for Jagriti Dham, which was deeply moved by the overwhelming audience response and the enthusiastic involvement of its residents. The event further reinforced the organisation’s philosophy of holistic living, where culture, community, and compassionate elderly care exist in harmony. The success of Aikyam – Series 2 once again affirmed Santoor Ashram’s role as a custodian of classical arts and Jagriti Dham’s vision of enriching lives through purposeful cultural engagement.

About Santoor Ashram

Santoor Ashram is a registered NGO founded by Pt. Tarun Bhattacharya, committed to promoting Indian classical music, mentoring financially backward and underprivileged young talents, and creating platforms that combine artistic excellence with social purpose.

About Jagriti Dham

Jagriti Dham is Kolkata’s most luxurious senior living community, offering a lifestyle that seamlessly blends comfort, dignity, culture, and community engagement for its residents.

For more details, contact:

Website: www.jagritidham.com

Email: contact@jagritidham.com

Phone: +91 89618 96167

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

New Delhi [India], January 3: Jaldapara Rhino Calf – The 1 st of 2026 presented the wildlife lovers with a memory that they will be talking about decades to come. In the green forests of West Bengal in the Jaldapara National Park, a new baby one-horned rhino calf was born. To the conservationists in India, this small calf is not only cute, but it is an indication that all the decades of hard work to preserve the species is beginning to pay off.

Jaldapara Rhino Calf – uncommon Miracle in the Grasslands.

One-horned rhinos have always been found in the grasslands of Jaldapara, but it is not an easy occurrence to see newborn calves. It is a healthy calf, a vibrant one, which symbolizes a real success of the wildlife protection efforts in India. This has made these calves fight a chance to survive as the chances of poaching are lower, and the habitats are being protected.

The rhino population in India has been experiencing severe challenges in the last century, but with the efforts to manage the situation such as Project Rhino and the intensive forest management programs, the situation is changing. Jaldapara has become one of the most successful conservation centers in the country, which unites the modern monitoring methods with the knowledge of the field of practice.

Why This Calf Is More than What You Think.

This is not a fairy tale about animals. It represents the birth of a Jaldapara Rhino Calf, a sign of ecological stability and effective habitat restoration. The healthy populations of breeding animals are a symptom that forests are not only surviving, but they are flourishing. Another web of biodiversity is supported by a thriving Jaldapara: deer, elephants, leopards, and hundreds of bird species are dependent on the same ecosystem.

According to conservationists, each calf in the world today is a stronghold against extinction tomorrow. Every healthy calf enhances genetic diversity, boosts resilience in the population and enhances India’s position in preserving wildlife.

The Science of Success.

Jaldapara National Park is not gambling with the rhinos. Intense anti-poaching patrols, habitat control and veterinary surveillance are protocol. Calves are closely monitored and fed, cared for, and watched over to avoid predators.

The difference is brought by modern tech. GPS collars, drones, and data-based monitoring are used to predict risks, follow the movement, and efficiently protect the species. The calf is being monitored to ensure it adjusts well to its habitat without human interference.

Symbolism Beyond Numbers

Jaldapara Rhino Calf is not only ecologically important, but it also acts as a hopeful indication of the broader conservation story of India. Amidst the climate panic and dwindling biodiversity worldwide, this one-horned rhino serves as a triumph of success achieved with the help of devotion, investment, and community engagement.

It is an occasion that reminds the country that when humans set out to preserve nature, they will succeed. This calf is living evidence that wildlife recovery in India is not just talk, but is actually being put into practice.

Jaldapara Rhino Calf and her place in the India Conservation Map.

Jaldapara Rhino Calf, which is found along the foothills of the Himalayas, is not just a rhino sanctuary. It is an example of how local involvement, science, and national policy can overlap to produce a long-term effect. The ecosystem is being taken care of on several fronts, from the local forest rangers to the central government support.

Tourism is another attraction of every new calf. Tourists are now flooding in to see rhinos in their natural habitat, and this is earning an eco-conscious income that is pumped back into protection initiatives.

What to Expect: Future of the Rhinos of India.

Although this calf is small in size, it is a colossal stride in conservation. Things do not stop at birth; surveillance, security and habitat enlargement are necessary. The success of Jaldapara Rhino Calf in India is a precedent of other rhino reserves in Assam, Kaziranga and Manas National Park.

If this trend continues, researchers estimate that India would not only stabilise but also significantly increase the population of one-horned rhinos in the coming decade.

Summary: The Calf That Inspires.

By the year 2026, when India will celebrate its 50th anniversary, the Jaldapara rhino calf will be a reminder that important, long-term conservation efforts can succeed. It is an icon of strength, optimism and the visible outcomes of the prudent human cultivation of nature. It is evidence to both wildlife enthusiasts and policy makers that even endangered species can recover with a vision, commitment and action.

It is not a calf that is born, but a beat of the wildlife rejuvenation in India.

Jaldapara National Park — Wildlife Wing, Directorate of Forests, Govt. of West Bengal
https://www.wildbengal.com/jaldapara-np.php

Jaldapara | Alipurduar District Official Site
https://alipurduar.gov.in/tourist-place/jaldapara/

PNN News

New Delhi [India], January 3: Big public-sector muscle just met a real public need. NTPC has committed serious capital to strengthen cancer care, and this time, the impact is measurable, immediate, and human.

NTPC Limited’s Western Region–I headquarters in Mumbai has signed a Memorandum of Agreement with the Gujarat Cancer & Research Institute for the upgradation of radiotherapy services. The partnership is not symbolic. It comes with a ₹23.16 crore commitment under NTPC’s CSR programme, aimed squarely at improving cancer treatment access in Gujarat.

The funding will be used at GCRI’s Siddhpur Satellite Centre in Ahmedabad. The focus is clear: procurement and installation of a high-energy Linear Accelerator, commonly known as a LINAC. For cancer patients, that machine is not just equipment. It’s precision, speed, and better outcomes.

The MoA was formally exchanged between Dr. Shashank Pandya, Director of GCRI, and Shri E. Satya Phani Kumar, Regional Executive Director (West–I), NTPC. Senior leadership from both organisations attended the ceremony, underscoring that this was not a routine CSR cheque handover. It was a strategic healthcare intervention.

Why does this matter, especially in India?

Cancer care in India often struggles at the intersection of demand, affordability, and infrastructure. Radiotherapy is one of the most critical components of cancer treatment, yet access to advanced machines remains uneven outside major metros.

The NTPC radiotherapy services upgradation directly addresses that gap. By funding a high-energy LINAC at a satellite centre, NTPC is decentralising advanced care. Patients who earlier had to travel long distances now get access closer to home. That saves time, money, and in many cases, lives.

For Gujarat, where GCRI already serves as a major oncology hub, this upgrade strengthens an existing backbone rather than creating a parallel system. That’s smart CSR. Build where trust and expertise already exist.

What the LINAC brings to the table?

A high-energy Linear Accelerator allows for precise targeting of tumours while sparing surrounding healthy tissue. That means fewer side effects, better tolerance, and improved treatment efficiency.

In practical terms, this upgrade increases patient throughput and expands the range of cancers that can be treated effectively. It also reduces treatment waiting times, a chronic issue in public and semi-public healthcare facilities.

The NTPC radiotherapy services upgradation is not about optics. It’s about capacity. More patients treated. Better technology deployed. Stronger outcomes delivered.

Leadership presence signals intent

The signing ceremony was attended by senior NTPC officials, including Shri Akhaya Kumar Patra, GM (OS), Shri A P Samal, CEO (NPUNL) and CGM (Nuclear), and Smt. Vandana Chaturvedi, Regional Head of HR (West–I). Members of NTPC’s CSR team were also present, alongside senior representatives from GCRI.

This level of leadership participation matters. It signals internal alignment and long-term commitment, not a one-off CSR headline.

NTPC’s evolving CSR playbook

NTPC has steadily moved beyond generic CSR initiatives. Its recent focus shows a tilt towards strengthening critical infrastructure, especially in healthcare, education, and community development.

The NTPC radiotherapy services upgradation fits squarely into that approach. It targets a high-impact area, deploys capital-intensive technology, and partners with a credible public healthcare institution.

From a policy perspective, this aligns with India’s broader push to improve non-communicable disease management. From a citizen’s perspective, it means better access to treatment that would otherwise remain out of reach.

CSR that actually scales

One of the quiet strengths of this initiative is scalability. Radiotherapy infrastructure upgrades create ripple effects. Trained staff, improved protocols, and upgraded facilities elevate overall care standards.

By investing in a satellite centre, NTPC ensures that benefits are not confined to a single urban pocket. This decentralised approach is exactly what Indian healthcare needs more of.

There is also a multiplier effect. Improved infrastructure attracts better talent, encourages further investment, and builds confidence among patients who might otherwise delay treatment.

Read More

New Delhi [India], January 3: India has now done the prominent. Blood that is used in transfusion is now subject to the same rulebook as medicines.

The blood transfusions have existed in a strange regulatory half-light for years. Everyone relied on them. Not many of them were wondering how evenly they were controlled. That uncertainty concludes with the Indian Pharmacopoeia 2026.

The 10th edition of the Indian Pharmacopoeia, the drug safety and efficacy encyclopedia of the country, was released quietly in New Delhi by the Union Health and Family Welfare and Chemicals and Fertilisers Minister JP Nadda, and increases the boundaries of the perimeter of drug safety in the country. Quietly, but decisively.

Pharmacopoeia standards are now uniformly available in legally enforceable blood components used in transfusion medicine. Not advisories. Not best practices. Norms that may be referred to by the inspectors and enforced by courts.

Indian Pharmacopoeia 2026: What Changed, Exactly?

Released the 10th edition of the Indian Pharmacopoeia 2026 in New Delhi today. This updated edition strengthens India’s commitment to quality, safety, and efficacy of medicines through robust and science-based standards. It reflects global best practices and highlights India’s… pic.twitter.com/NsCDtTKeNK

— Jagat Prakash Nadda (@JPNadda) January 2, 2026

The official book of drug standards in India is the Indian Pharmacopoeia. It is governed by the Drugs and Cosmetics Act, 1940 and its regulations are binding. Licences, distribution, and inspections. Everything flows from it.

The Indian Pharmacopoeia 2026 expands that framework in a manner not previously done by its predecessors. It is the first time that it presents 20 monographs devoted to blood and blood components.

That act alone would bring blood banks and hospital transfusion services under more regulatory scrutiny. Less interpretation. Fewer grey zones.

What Blood Products Are Controlled Nowadays?

The scope is not symbolic. It is granular.

Whole blood, even irradiated ones, is covered. So also are red blood cell products in their various forms: packed cells, additive solution RBCs, leucodepleted units, buffy coat removed cells, cryopreserved RBCs, and washed RBCs.

Plasma products are also characterised in the same way. Whole-blood and apheresis fresh frozen plasma. Cryoprecipitate. Cryo-poor plasma.

Platelets, which are usually the most difficult element to deal with, are also placed under the same standards. PRP, pooled platelets, random donor platelets, buffy coat platelets and apheresis-derived platelets, such as additive solution and two-unit platelets.

Even the granulocyte components derived by either apheresis or buffy coat pooling of the buffy coat qualify to be listed.

In case it gets into the blood of the patient during any transfusion process, the Indian Pharmacopoeia 2026 details its measurements, tests, storage and labelling.

The reason this is important.

Transfusion of blood is not a specialised branch of medicine. It is ordinary, emergency, and usually life-saving.

Trauma care. Cancer treatment. Major surgeries. Childbirth complications. Inherited blood disorders. The public hospitals in India are reliant on blood on a daily basis.

Equal standards minimise inter-facility variation. They reduce risks of contamination, mishandling and silent failure. Accountability is also made easier by them. In case of something going wrong, the benchmark is not argued anymore.

That transparency is important in the case of a healthcare system that operates at scale.

Drugs Come Under Stricter Examination as well.

Blood is not even the half-upgrade.

Indian pharmacopoeia 2026 incorporates 121 new standards of drugs, and the total number of monographs is 3340. Every monograph provides an abbreviation of the way a medicine should be prepared, administered, stored, and labelled.

This empowers the regulators to take action against poor or unsafe medicines. It also increases the compliance level among the manufacturers who are on the other side of the line.

Here, there is a kind of public-health aspect which we cannot overlook.

Medicines utilised in national health programmes have become the subject of more critical quality scrutiny. Tuberculosis drugs. Diabetes medication. Cancer therapies. It is a long-term therapy for millions of people, most of whom depend solely on government health care systems.

Here, consistency is not cosmetic. It is survival.

Surveillance Is Catching Up

Standards are best in conjunction with vigilance.

The Pharmacovigilance Programme of India, operated by the Indian Pharmacopoeia Commission in India, has been on a low profile in enhancing its international status. In the years between 2009 and 2014, India was number 123 in the world with regard to donations to the pharmacovigilance database of the World Health Organisation. By 2025, it reached 8th.

That leap indicates an increase in prompt reporting of adverse drug reactions and actions taken by the regulators. Indian Pharmacopoeia 2026 feeds on this by further impeding the quality control further upstream, before damage is caused.

Why It Makes Sense?

There is a high disease burden in India. Volume is managed by the public hospitals. Complexity is dealt with in private hospitals. They both require the blood and needed medicines to work exactly as they should.

Meanwhile, India is an international pharmaceutical provider. International trust is becoming more and more influenced by domestic standards.

With the combination of regulating blood components and medicines, the Indian Pharmacopoeia 2026 is harmonising patient safety and manufacturing discipline. It also portends that regulators are ready to fill longstanding blanks even though they are not seated in comfortable locations, such as transfusion medicine.

Not dramatic. Just necessary.

What Comes Next?

Everything will be determined by implementation.

Blood banks will be forced to tighten operations. There will be a need to have improved documentation in hospitals. Uniformity will be required of the inspectors. The pressure will be on the manufacturers.

Nevertheless, it is clear where the direction is.

Indian Pharmacopoeia 2026 is not the news or the applause. It concerns the reduced number of avoidable risks within hospitals. About blood that is safer. Drugs that do what they are supposed to do. At times, reform is most effective when it is not aimed at impressing.

This is just a simple way of fixing plumbing.

Read More

New Delhi [India], December 30: The Divyang Para Sports Association of Delhi (DPSA) successfully organised the 3rd Senior and 2nd Junior & Sub-Junior Delhi State Para Powerlifting Championship 2025–26 on Saturday, 27 December 2025, at the prestigious Jawaharlal Nehru (JLN) Stadium, New Delhi. The championship emerged as a powerful confluence of social responsibility, sporting excellence, and inclusive development.

On this distinguished occasion, Mr. Vinay Kumar Dubey, Chairman of the VKDL NPA Advisory Council, renowned legal expert, and member of the Hindi Advisory Committee (Official Language Department), Ministry of Home Affairs, Government of India, was specially honoured for his outstanding contribution to social service, financial reforms, and his commitment to nation-building.

The event was inaugurated in the esteemed presence of Dr. Arvind Menon, National Secretary of the Bharatiya Janata Party, IPS Devesh Srivastava, Special Commissioner of Delhi Police, and the chief guest Vinay Kumar Dubey.

Addressing the gathering, Dr. Arvind Menon stated that “initiatives like Khelo India and Fit India are providing equal opportunities to every section of society, especially empowering para-athletes to move forward with confidence.”

IPS Devesh Srivastava lauded the courage, discipline, and dedication of para players and encouraged them to aim for excellence at national and international platforms.

DPSA President Ms. Parul Singh highlighted that the championship marks a significant step towards strengthening para sports in the national capital.

While accepting the honour, Vinay Kumar Dubey remarked, “Para athletes represent the true strength of our nation. Being part of such initiatives and contributing to their motivation is a matter of immense pride for me.”

Notably, the VKDL NPA Advisory Council is actively working across the country in coordination with banks to resolve major financial and Non-Performing Asset (NPA) cases. With operations in Delhi, Mumbai, and Bengaluru, the organisation is playing a vital role in relieving businesses from debt stress and contributing towards the vision of a debt-free India.

Vinay Kumar Dubey has also remained highly active in the social sector. His recent initiatives, including large-scale community conferences, cow protection activities, and social welfare programs, have established him as a sensitive, committed, and people-centric leader.

Political circles are abuzz with discussions that if the Bharatiya Janata Party offers him an opportunity from his native district Pratapgarh (Patti) or his professional base Mumbai, he may step into active politics in the near future.

Following the event, Vinay Kumar Dubey received an outpouring of congratulations from friends and well-wishers across the country.

It is noteworthy that Vinay Kumar Dubey is the founder of V.K. Dubey & Associates, United Legal, KNS Legal, and VKDL Corporation. He also serves as the National Legal Head of the Prime Minister’s Atmanirbhar Bharat Abhiyan Organisation, through which he actively promotes public awareness regarding various government schemes and welfare initiatives.

Additionally, he is closely associated with the Pratapgarh Parivar Organisation, which works dedicatedly for the development of Pratapgarh district in Uttar Pradesh and the welfare of Pratapgarh natives residing across India and abroad.

Vinay Kumar Dubey is also the founder and patron of several charitable institutions, including the Kumari Mamta Devi Memorial Trust, Brahmin International Business Organisation (BIBO), Gyanodaya Seva Samiti, and Kisan Kranti Morcha, all of which are actively contributing in the fields of education and healthcare.

Furthermore, as the National Secretary of KNS Group, he has played a crucial role in providing livelihood opportunities to thousands of underprivileged women in Uttar Pradesh by promoting small-scale employment and self-reliance.

Owing to his sustained commitment to social welfare, legal advocacy, and nation-building initiatives, Vinay Kumar Dubey has built a strong and positive social-political image among senior leaders of the BJP and RSS.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

New Delhi [India], December 29:  When the Defence Acquisition Council cleared proposals worth nearly Rs 79,000 crore, it quietly reset the tempo of India’s military modernisation.

The Defence Acquisition Council, chaired by Defence Minister Rajnath Singh, has accorded Acceptance of Necessity for a sweeping set of procurements across the Indian Army, Navy and Air Force. The approvals came during the DAC meeting on December 29, 2025. On paper, it’s a number. In reality, it’s a direction.

Rs 79,000 crore is not pocket change. But more than the figure, it’s the selection that matters. Drones. Precision rockets. Long-range missiles. Radars that spot what the naked eye never will. Systems meant for how wars actually unfold now, not how they looked a decade ago.

Indian Army: Seeing First, Striking Cleaner

The Army’s approvals read like a checklist of modern battlefield priorities. Start with Loiter Munition Systems for Artillery Regiments. These are not dumb rounds fired and forgotten. They hang, they watch, they wait. Then they strike tactical targets with precision. That pause, that ability to choose, changes outcomes.

Low-Level Light-Weight Radars are next. Their job is simple, though the tech isn’t. Detect and track small, low-flying unmanned aerial systems. In other words, spot hostile drones before they do damage. Given how cheap drones have become and how expensive their impact can be, this is overdue.

Then there’s the Long Range Guided Rocket Ammunition for the Pinaka Multiple Launch Rocket System. Pinaka already packs a punch. These guided rockets extend its reach and tighten its accuracy, allowing engagement of high-value targets from farther away. Distance, in warfare, buys time. Time buys options.

The Integrated Drone Detection and Interdiction System Mk-II rounds out the Army list. With enhanced range, it is designed to protect vital assets not just in Tactical Battle Areas but also deeper in the hinterland. That detail matters. Threats don’t politely stop at the front line anymore.

Put together, the Army’s acquisitions lean heavily toward awareness and precision. Less guesswork. Fewer blind spots. More control.

Indian Navy: Quiet Strength, Wide Eyes

Naval approvals often get less attention. They shouldn’t. This round begins with Bollard Pull Tugs. Not glamorous, yes. Essential, absolutely. These tugs assist ships and submarines during berthing, unberthing and manoeuvring in confined waters and harbours. As fleet size grows, harbour efficiency becomes a strategic asset.

High-frequency software-defined radios in manpack form are also cleared. These enhance long-range secure communication during boarding and landing operations. It’s the kind of capability you only miss when it fails. The Navy clearly doesn’t plan on missing it.

The standout, though, is the leasing of High Altitude Long Range Remotely Piloted Aircraft Systems. HALE RPAS platforms mean persistent Intelligence, Surveillance and Reconnaissance. They also mean credible Maritime Domain Awareness across the Indian Ocean Region.

That ocean is not empty anymore. Persistent eyes in the sky change the equation. Quietly. Constantly.

Indian Air Force: Reach Further, Train Smarter

For the Indian Air Force, the DAC approvals focus on three things that pilots care about deeply. Safety. Range. Readiness.

The Automatic Take-off Landing Recording System is one of those unflashy systems that ends up doing heavy lifting. High-definition, all-weather recording of take-offs and landings fills gaps in the aerospace safety environment. It helps analyse, learn and prevent. That alone justifies its place.

Astra Mk-II missiles bring the edge back to air combat. With enhanced range, these missiles allow fighter aircraft to neutralise adversary aircraft from large standoff distances. In aerial warfare, distance is leverage. Astra Mk-II adds more of it.

Training gets a solid upgrade through the Full Mission Simulator for the Light Combat Aircraft Tejas. Simulators allow pilots to rehearse scenarios repeatedly, safely and cheaply. For a growing fleet, this is not optional. It’s foundational.

Then there’s SPICE-1000 Long Range Guidance Kits. These kits enhance precision strike capability from long distances. Again, the theme repeats. Hit accurately. Stay safer.

Why This Clearance Matters?

There’s a temptation to treat DAC approvals as bureaucratic milestones. That misses the point. These clearances reflect a shift in mindset. From reactive to anticipatory. From volume to precision.

India’s security environment is layered. Mountains, oceans, airspace, and now cyberspace hovering over all of it. The systems cleared here acknowledge that complexity without pretending there’s a silver bullet.

There’s also a broader signal. Capability development is being treated as continuous, not episodic. That alone is progress.

Read More

Surat (Gujarat) [India], December 29: The second edition of the ‘Run for Girl Child’ charity run, organised by Dr Hedgewar Seva Smriti Trust for the all-round development of girls from exploited, deprived, and distressed sections of society, will be held on January 4, 2026, at the VNSGU Campus, Surat.

This information was shared by event committee co-convenor Amitbhai Gajjar during a press conference. Around 8,000 to 10,000 runners are expected to participate in this charity run. The marathon will feature various categories, including 21 km, 10 km, 5 km, and 2 km. Winners will receive a total cash prize of ₹2,20,000.

AM/NS is supporting the event as the main sponsor, while Ramkrishna Diamond, PPL, and Rajkot Nagrik Sahakari Bank have joined as associate donors. ICC Chairman Jay Shah will be present as the chief guest on this occasion. Prominent city industrialists and co-convenors of the organising committee, Shri Ghanshyam Shankar Amitbhai Gajjar (Chairman, Peoples Bank), Shyamji Rathi, Rajeshji Surana, and Rakeshji Kansal, have also been invited.

Committee co-convenor Shyamji Rathi stated that ‘Run for Girl Child’ is not just a race, but a movement for the holistic upliftment of girls. The Trust has been consistently working to empower exploited, deprived, and distressed girls living in slum areas across five dimensions: physical, mental, spiritual, intellectual, and social development. Last year, there were only 7 Kishori Vikas Kendras, which have now grown to 159 active centres. Additionally, the Trust’s ‘Gyan Mandir’ project has expanded from 60 centres to 105 centres. Through this marathon, the target for the coming year is to increase Kishori Vikas Kendras from 159 to 500 and expand the Gyan Mandir project from 105 to 300 centres. The entire proceeds from this charity run will be utilised for girls’ education, development, and welfare activities.

Notably, Dr. Hedgewar Seva Smriti Trust was established in 1988. The Trust works in four major areas: social service, education, self-reliance, and health. Shri Ranchhodbhai Dholiya serves as the President of Dr Hedgewar Trust, while Nitin Patel holds the position of Minister.

PNN News

New Delhi [India], December 29: AYUSH medicines don’t float in regulatory limbo. They operate under a dense, rule-heavy system that most critics never bother to read. Here’s what actually keeps Ayurveda, Siddha, Unani and Homoeopathy drugs in check.

India’s AYUSH sector sits at an awkward crossroads. Hugely popular. Deeply traditional. Constantly questioned. What rarely gets attention is the regulatory scaffolding holding it together. It exists. It’s detailed. And it’s far from symbolic.

At the centre of this system is AYUSH drug quality regulation, a framework built on testing, surveillance, certification and enforcement. Let’s break it down without the fog.

PCIM&H and the Backbone of AYUSH Drug Quality Regulation

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy, or PCIM&H, operates under the Ministry of Ayush. Its role is blunt and non-negotiable. It acts as the appellate drug testing laboratory for Ayurveda, Siddha, Unani and Homoeopathy drugs.

That means when quality disputes arise, PCIM&H is the final word on identity, purity, strength and composition. No opinions. Just lab results.

PCIM&H also publishes pharmacopoeial standards and formularies. These documents are not academic fluff. Under the Drugs and Cosmetics Act, 1940, compliance with these standards is mandatory for manufacturers. Miss them, and you are in violation of the law.

Drug Testing Laboratories and Rule 160 A to J

AYUSH drug quality regulation is anchored in Rule 160 A to J of the Drugs Rules, 1945. These rules govern how drug testing laboratories are approved to test Ayurvedic, Siddha and Unani medicines.

As of today, 34 State Drug Testing Laboratories have received central support to upgrade infrastructure and functionality. Beyond that, 108 laboratories are officially approved or licensed to test AYUSH drugs and raw materials.

Add to this three Regional Research Institutions under the Central Council for Research in Ayurvedic Sciences, approved under Rule 160E. These labs aren’t decorative. They are legally empowered testing bodies.

Pharmacovigilance for AYUSH Drugs Isn’t Optional

AYUSH drug quality regulation doesn’t stop at manufacturing. It extends into the market.

Under the Central Sector Scheme Ayush Oushadhi Gunavatta Evam Uttpadan Samvardhan Yojana, or AOGUSY, India runs a nationwide pharmacovigilance programme for AYUSH drugs.

The structure is three-tiered:

• One National Pharmacovigilance Centre.
• Five Intermediary Centres.
• Ninety-seven Peripheral Centres spread across the country.

Their mandate is simple. Monitor adverse reactions. Track misleading advertisements. Report violations to State Regulatory Authorities for action.

So far, this network has conducted 3,533 awareness programmes, reaching over 3.18 lakh beneficiaries. That’s not passive regulation. That’s boots on the ground.

Cracking Down on Misleading Claims

One of the loudest criticisms of AYUSH products is exaggerated advertising. The system acknowledges that risk and actively targets it.

Pharmacovigilance centres are specifically tasked with identifying misleading advertisements. When found, these are escalated to state regulators. Enforcement follows existing legal provisions. No parallel justice. No shortcuts.

The objective is consumer protection. Plain and simple. Verified claims stay. Unverified ones don’t.

Global-Grade Certifications for AYUSH Products

AYUSH drug quality regulation also looks outward.

India extends the World Health Organization’s Certification of Pharmaceutical Product, or CoPP, scheme to Ayurvedic, Siddha and Unani medicines. This certificate is administered by the Central Drugs Standard Control Organisation.

The process includes joint inspections by CDSCO, the Ministry of Ayush and State Licensing Authorities. It’s not a paperwork exercise. Manufacturing units are physically inspected.

Separately, the Quality Council of India runs a Quality Certification Scheme. Products meeting domestic and international standards receive the Ayush Mark, based on third-party evaluation.

That’s how export credibility is built. Slowly. Methodically.

AOGUSY and the Money Behind Quality

Regulation without funding collapses. The Ministry of Ayush knows this.

Under AOGUSY, the government has allocated Rs 122 crore over five years, from 2021–22 to 2025–26. One key component focuses on upgrading AYUSH pharmacies and drug testing laboratories.

Better equipment. Better compliance. Fewer excuses.

Legal Architecture of AYUSH Drug Regulation

The Drugs and Cosmetics Act, 1940 doesn’t treat AYUSH as an afterthought. It has exclusive chapters and schedules for it.

Ayurveda, Siddha, Sowa-Rigpa and Unani drugs fall under Chapter IVA and Schedule I of the Act, along with Rules 151 to 169 and Schedules E(I), T and TA.

Homoeopathic drugs are governed by a separate set of provisions, including Schedule 4A of the Act and multiple rules and schedules under the Drugs Rules, 1945.

Manufacturers must comply with Good Manufacturing Practices under Schedule T. Proof of safety and effectiveness is mandatory. There’s no opt-out clause.

CDSCO’s AYUSH Vertical and Inspections

To tighten enforcement, the Ministry of Ayush has established a dedicated AYUSH vertical within CDSCO.

This unit conducts inspections of manufacturing facilities in coordination with state drug inspectors and licensing authorities. The goal is consistent enforcement across states, not regulatory patchwork.

Think of it as centre-state teamwork with lab coats.

Research, Validation and the Ayurgyan Scheme

Quality regulation isn’t complete without research.

Since 2021–22, the Ministry of Ayush has implemented the Ayurgyan Scheme to support research and innovation. It has three components:

– Capacity building and continuing medical education.
– Research and innovation.
– Ayurveda Biology Integrated Health Research.

This feeds directly into scientific validation, not belief-based promotion.

Research Councils and Scientific Oversight

India has established dedicated research councils for Ayurveda, Unani, Homoeopathy, Siddha, and Yoga and Naturopathy. These bodies coordinate national research on medicinal plants, drug standardisation, pharmacology, clinical studies and tribal healthcare.

Their work is conducted through institutes across the country and in collaboration with universities and hospitals.

PCIM&H also runs regular training programmes for state regulators, lab personnel and quality control staff. Regulation improves when people actually know the rules.

Read More